A Randomized Control Trial Comparing the Iron Profile Changes Following Intravenous Ferric Carboxymaltose and Iron Sucrose in the Treatment of Iron Deficiency Anemia in Pregnancy
Randomized control trial shows significant improvements in iron profile with ferric carboxymaltose in pregnant women, indicating better treatment efficacy.
Key Points
Ferric carboxymaltose significantly improves iron profile parameters in pregnant women compared to iron sucrose, and reticulocytosis rose more in the FCM group.
At 4 weeks, mean hemoglobin was 11.42 g/dL with FCM and 11.00 g/dL with ISC, showing substantial improvement in the FCM group.
The study involved 86 antenatal women with iron deficiency anemia, randomized into two equal treatment groups receiving FCM and ISC.
The findings highlight the potential benefits of FCM over ISC in treating iron deficiency anemia during pregnancy.